JP2021500401A5 - - Google Patents

Info

Publication number
JP2021500401A5
JP2021500401A5 JP2020542541A JP2020542541A JP2021500401A5 JP 2021500401 A5 JP2021500401 A5 JP 2021500401A5 JP 2020542541 A JP2020542541 A JP 2020542541A JP 2020542541 A JP2020542541 A JP 2020542541A JP 2021500401 A5 JP2021500401 A5 JP 2021500401A5
Authority
JP
Japan
Prior art keywords
linear
nr7r8
optionally substituted
independently selected
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020542541A
Other languages
English (en)
Japanese (ja)
Other versions
JP7342010B2 (ja
JP2021500401A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/056379 external-priority patent/WO2019079519A1/en
Publication of JP2021500401A publication Critical patent/JP2021500401A/ja
Publication of JP2021500401A5 publication Critical patent/JP2021500401A5/ja
Priority to JP2023140497A priority Critical patent/JP7817972B2/ja
Application granted granted Critical
Publication of JP7342010B2 publication Critical patent/JP7342010B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020542541A 2017-10-18 2018-10-17 広域スペクトルの抗ウイルス組成物及び方法 Active JP7342010B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023140497A JP7817972B2 (ja) 2017-10-18 2023-08-30 広域スペクトルの抗ウイルス組成物及び方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762574067P 2017-10-18 2017-10-18
US62/574,067 2017-10-18
PCT/US2018/056379 WO2019079519A1 (en) 2017-10-18 2018-10-17 BROAD SPECTRUM ANTIVIRAL COMPOSITIONS AND METHODS

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023140497A Division JP7817972B2 (ja) 2017-10-18 2023-08-30 広域スペクトルの抗ウイルス組成物及び方法

Publications (3)

Publication Number Publication Date
JP2021500401A JP2021500401A (ja) 2021-01-07
JP2021500401A5 true JP2021500401A5 (https=) 2022-10-07
JP7342010B2 JP7342010B2 (ja) 2023-09-11

Family

ID=66173872

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020542541A Active JP7342010B2 (ja) 2017-10-18 2018-10-17 広域スペクトルの抗ウイルス組成物及び方法
JP2023140497A Active JP7817972B2 (ja) 2017-10-18 2023-08-30 広域スペクトルの抗ウイルス組成物及び方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023140497A Active JP7817972B2 (ja) 2017-10-18 2023-08-30 広域スペクトルの抗ウイルス組成物及び方法

Country Status (11)

Country Link
US (3) US11459321B2 (https=)
EP (2) EP4667471A3 (https=)
JP (2) JP7342010B2 (https=)
KR (1) KR102822639B1 (https=)
CN (2) CN120518604A (https=)
AU (2) AU2018350999B2 (https=)
CA (1) CA3079396A1 (https=)
ES (1) ES3006445T3 (https=)
IL (1) IL273990B2 (https=)
MX (2) MX2020004475A (https=)
WO (1) WO2019079519A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11093787B2 (en) 2016-07-01 2021-08-17 The Board Of Regents Of The University Of Texas System Methods, apparatuses, and systems for creating 3-dimensional representations exhibiting geometric and surface characteristics of brain lesions
CN120518604A (zh) * 2017-10-18 2025-08-22 艾弗里斯生物有限责任公司 广谱抗病毒组合物和方法
EP4175646A1 (en) * 2020-07-01 2023-05-10 Iachettini, Giampietro Modified adenosine nucleoside for use in the treatment of viral infections
US20240109883A1 (en) 2020-12-31 2024-04-04 Evrys Bio, Llc Anti-Tumor Compositions and Methods

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US5858784A (en) 1991-12-17 1999-01-12 The Regents Of The University Of California Expression of cloned genes in the lung by aerosol- and liposome-based delivery
US6042820A (en) 1996-12-20 2000-03-28 Connaught Laboratories Limited Biodegradable copolymer containing α-hydroxy acid and α-amino acid units
US6472375B1 (en) 1998-04-16 2002-10-29 John Wayne Cancer Institute DNA vaccine and methods for its use
US7795249B2 (en) 2006-12-22 2010-09-14 Millennium Pharmaceuticals, Inc. Certain pyrazoline derivatives with kinase inhibitory activity
US20150335657A1 (en) 2014-05-05 2015-11-26 The Trustees Of Princeton University Methods for Modulating Sirtuin Enzymes
JPWO2016027879A1 (ja) * 2014-08-22 2017-06-01 塩野義製薬株式会社 インテグラーゼ阻害活性を有する多環性ピリドン誘導体
EP3218373B1 (en) * 2014-11-10 2020-07-22 Evrys Bio, LLC Anti-hcmv compositions and methods
US10723708B2 (en) 2014-11-10 2020-07-28 Evrys Bio, Llc Anti-HCMV compositions and methods
CN107108610B (zh) * 2014-12-30 2019-06-04 豪夫迈·罗氏有限公司 用于治疗和预防肝炎b病毒感染的新的四氢吡啶并嘧啶和四氢吡啶并吡啶化合物
WO2016177655A1 (en) * 2015-05-04 2016-11-10 F. Hoffmann-La Roche Ag Tetrahydropyridopyrimidines and tetrahydropyridopyridines as inhibitors of hbsag (hbv surface antigen) and hbv dna production for the treatment of hepatitis b virus infections
CN120518604A (zh) 2017-10-18 2025-08-22 艾弗里斯生物有限责任公司 广谱抗病毒组合物和方法

Similar Documents

Publication Publication Date Title
JP2021500401A5 (https=)
JP2021513534A5 (https=)
RU2020110780A (ru) Ингибитор fgfr и его медицинское применение
JP2019104748A5 (https=)
JP2016514159A5 (https=)
JP2015024998A5 (https=)
IL272115B (en) An aryl-phosphorus-oxygen compound as an egfr kinase inhibitor
RU2021139070A (ru) Ингибиторы ERBB/BTK
UY38297A (es) Compuestos derivados de 3-(5-hidroxi-1-oxoisoindolin-2-il)piperidina-2,6-diona, composiciones, métodos y usos de los mismos
RU2018106914A (ru) 1,3,4,-оксадизоламидное производное соединение в качестве ингибитора гистондеацетилазы 6 и содержащая его фармацевтическая композиция
AR117189A1 (es) Derivados de 6,7-dihidro-4h-pirazolo[1,5-a]pirazin indol-2-carboxamidas activos contra el virus de la hepatitis b (vhb)
JP2014055161A5 (https=)
RU2011102396A (ru) Аминосоединения и их медицинское применение
RU2535347C3 (ru) Индуцирующие апоптоз средства для лечения злокачественной опухоли и иммунных и аутоиммунных заболеваний
JP2016518434A5 (https=)
JP2008505194A5 (https=)
JP2015520769A5 (https=)
JP2016522172A5 (https=)
RU2013116924A (ru) N1/n2-лактамные ингибиторы ацетил-коа-карбоксилаз
RU2020131276A (ru) Терапевтические соединения и композиции
RU2018147263A (ru) Фторированные 2-амино-4-(замещенные амино)фенилкарбаматные производные
JP2018501215A5 (https=)
JP2015535847A5 (https=)
AR116947A1 (es) Derivados de urea 6,7-dihidro-4h-pirazolo[1,5-a]pirazinas-indol-2-carboxamidas activas contra el virus de la hepatitis b (vhb)
RU2016134130A (ru) ПИРАЗОЛО[1,5-а]ПИРИМИДИНЫ В КАЧЕСТВЕ ПРОТИВОВИРУСНЫХ СОЕДИНЕНИЙ